IL13 and Alzheimer disease: Recent studies have shown that the activation of the JAK (Janus kinase)- STAT (signal transducer and activator of transcription) signaling pathway is essential for mediating downstream inflammatory cytokines in AD patients, including IL-4, IL-5, IL-13, IL-31, IL-22, and TSLP (17).